OrbiMed’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,306
| Closed | -$1.54M | – | 171 |
|
|
2021
Q1 | $1.54M | Sell |
11,306
-6,666
| -37% | -$905K | 0.01% | 149 |
|
|
2020
Q4 | $1.63M | Sell |
17,972
-51,824
| -74% | -$4.71M | 0.01% | 144 |
|
|
2020
Q3 | $5.19M | Hold |
69,796
| – | – | 0.07% | 124 |
|
|
2020
Q2 | $5.95M | Sell |
69,796
-16,666
| -19% | -$1.42M | 0.08% | 112 |
|
|
2020
Q1 | $6.25M | Sell |
86,462
-9,507
| -10% | -$687K | 0.11% | 96 |
|
|
2019
Q4 | $6.85M | Hold |
95,969
| – | – | 0.1% | 90 |
|
|
2019
Q3 | $5.04M | Hold |
95,969
| – | – | 0.1% | 89 |
|
|
2019
Q2 | $5.15M | Hold |
95,969
| – | – | 0.08% | 103 |
|
|
2019
Q1 | $6.82M | Buy |
95,969
+43,334
| +82% | +$3.08M | 0.11% | 92 |
|
|
2018
Q4 | $4.2M | Sell |
52,635
-3,792
| -7% | -$303K | 0.08% | 101 |
|
|
2018
Q3 | $26.3M | Sell |
56,427
-5,000
| -8% | -$2.33M | 0.32% | 78 |
|
|
2018
Q2 | $24.4M | Hold |
61,427
| – | – | 0.29% | 76 |
|
|
2018
Q1 | $18.8M | Hold |
61,427
| – | – | 0.23% | 84 |
|
|
2017
Q4 | $18.1M | Hold |
61,427
| – | – | 0.23% | 82 |
|
|
2017
Q3 | $33.6M | Hold |
61,427
| – | – | 0.32% | 74 |
|
|
2017
Q2 | $36.6M | Hold |
61,427
| – | – | 0.38% | 66 |
|
|
2017
Q1 | $26.4M | Hold |
61,427
| – | – | 0.3% | 70 |
|
|
2016
Q4 | $31.6M | Hold |
61,427
| – | – | 0.4% | 56 |
|
|
2016
Q3 | $26.3M | Hold |
61,427
| – | – | 0.3% | 68 |
|
|
2016
Q2 | $25.8M | Buy |
+61,427
| New | +$25.8M | 0.27% | 66 |
|